In a filing, Cg Oncology Inc revealed its Director POST LEONARD E unloaded Company’s shares for reported $28000.0 on Mar 17 ’25. In the deal valued at $28.00 per share,1,000 shares were sold. As a result of this transaction, POST LEONARD E now holds 0 shares worth roughly $0.0.
Then, LEONARD E POST bought 4,000 shares, generating $111,200 in total proceeds.
Before that, POST LEONARD E sold 1,000 shares. Cg Oncology Inc shares valued at $28,610 were divested by the Director at a price of $28.61 per share. As a result of the transaction, POST LEONARD E now holds 0 shares, worth roughly $0.0.
Scotiabank initiated its Cg Oncology Inc [CGON] rating to a Sector perform in a research note published on April 16, 2025; the price target was $23. A number of analysts have revised their coverage, including TD Cowen’s analysts, who began to cover the stock in early January with a ‘”a Buy”‘ rating. UBS began covering CGON with “Buy” recommendation on October 24, 2024. RBC Capital Mkts started covering the stock on September 23, 2024. It rated CGON as “an Outperform”.
Price Performance Review of CGON
On Tuesday, Cg Oncology Inc [NASDAQ:CGON] saw its stock jump 0.34% to $20.48. Over the last five days, the stock has gained 2.09%. Cg Oncology Inc shares have fallen nearly -28.59% since the year began. Nevertheless, the stocks have fallen -42.02% over the past one year. While a 52-week high of $46.99 was reached on 01/07/25, a 52-week low of $14.80 was recorded on 04/09/25. SMA at 50 days reached $24.60, while 200 days put it at $31.58.
Levels Of Support And Resistance For CGON Stock
The 24-hour chart illustrates a support level at 19.86, which if violated will result in even more drops to 19.23. On the upside, there is a resistance level at 21.15. A further resistance level may holdings at 21.82. The Relative Strength Index (RSI) on the 14-day chart is 42.90, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 1.42, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 29.35%. Stochastics %K at 59.32% indicates the stock is a holding.
How much short interest is there in Cg Oncology Inc?
A steep rise in short interest was recorded in Cg Oncology Inc stocks on 2025-03-31, growing by 1.05 million shares to a total of 8.05 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-28 was 7.0 million shares. There was a rise of 13.03%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on August 28, 2024 when ROTH MKM began covering the stock and recommended ‘”a Buy”‘ rating along with a $65 price target.
